Additionally, in the in vivo studies using mice and rats, anti-FGF2 aptamer, umedaptanib pegol (formerly called RBM-007), inhibits not only FGF2-induced angiogenesis but also laser-induced CNV, and CNV with fibrosis [14]. This evidence concerns the gene FGF2 and fibrosis.